Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy

Psychological Medicine

Volumn 41, Issue 1, 2011, Pages 151-162

  Frank, E ^a   Cassano, G B ^b   Rucci, P ^a   Thompson, W K ^c   Kraemer, H C ^d   Fagiolini, A ^e   Maggi, L ^b   Kupfer, D J ^a   Shear, M K ^f   Houck, P R ^a   Calugi, S ^b   Grochocinski, V J ^a   Scocco, P ^g   Buttenfield, J ^a   Forgione, R N ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF SIENA   (Italy)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g ULSS 16   (Italy)

Author keywords

Depression; interpersonal psychotherapy; moderators; predictors; treatment

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; AFFECT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; TIME;

ADULT; AFFECT; ANXIETY; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; PSYCHOTHERAPY; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 78650308569     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291710000553     Document Type: Article

References (35)

1. Akiskal HS (2007). The emergence of the bipolar spectrum: validation along clinical epidemiologic and familial-genetic lines. Psychopharmacology Bulletin 40, 99-115.
2. APA (2000). Handbook of Psychiatric Measures, 1st edn. American Psychiatric Association: Washington, DC.
3. Barber JP, Muenz LR (1996). The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: empirical findings from the treatment for depression collaborative research program. Journal of Consulting and Clinical Psychology 64, 951-958.
4. Beck AT, Rush AJ, Shaw BF, Emery G (1979). Cognitive Therapy of Depression. Guilford Press: New York.
5. Brückl TM, Wittchen HU, Höfler M, Pfister H, Schneider S, Lieb R (2007). Childhood separation anxiety and the risk of subsequent psychopathology: results from a community study. Psychotherapy and Psychosomatics 76, 47-56.
6. Cassano GB, Benvenuti A, Miniati M, Calugi S, Mula M, Maggi L, Rucci P, Fagiolini A, Perris F, Frank E (2009a). The factor structure of lifetime depressive spectrum in patients with unipolar depression. Journal of Affective Disorders 115, 87-99.
7. Cassano GB, Michelini S, Shear MK, Coli E, Maser JD, Frank E (1997). The panic-agoraphobic spectrum: a descriptive approach to the assessment and treatment of subtle symptoms. American Journal of Psychiatry 154, 27-38.
8. Cassano GB, Mula M, Rucci P, Miniati M, Frank E, Kupfer DJ, Oppo A, Calugi S, Maggi L, Gibbons R, Fagiolini A (2009b). The structure of lifetime manic-hypomanic spectrum. Journal of Affective Disorders 112, 59-70.
9. Cassano GB, Rucci P, Frank E, Fagiolini A, Dell'Osso L, Shear MK, Kupfer DJ (2004). The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. American Journal of Psychiatry 161, 1264-1269.
10. Dell'Osso L, Armani A, Rucci P, Frank E, Fagiolini A, Corretti G, Shear MK, Grochocinski VJ, Maser JD, Endicott J, Cassano GB (2002a). Measuring mood spectrum: comparison of interview (SCI-MOODS) and self-report (MOODS-SR) instruments. Comprehensive Psychiatry 43, 69-73.
11. Dell'Osso L, Rucci P, Cassano GB, Maser JD, Endicott J, Shear MK, Sarno MK, Saettoni M, Grochocinski VJ, Frank E (2002b). Measuring social anxiety and obsessive-compulsive spectra: comparison of interviews and self-report instruments. Comprehensive Psychiatry 43, 81-87.
12. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O'Reardon JP, Lovett ML, Gladis MM (2005). Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry 62, 409-416.
13. Dimidjian S, Dobson KS, Kohlenberg RJ, Gallop R, Markley DK, Atkins DC, Hollon SD, Schmaling KB, Addis ME, McGlinchey JB, Gollan JK, Dunner DL, Jacobson NS (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology 74, 658-670.
14. Dupont WD, Plummer WD (1997). PS power and sample size program available for free on the internet. Contemporary Clinical Trials 18, 274.
15. Fagiolini A, Dell'Osso L, Pini S, Armani A, Bouanani S, Rucci P, Cassano GB, Endicott J, Maser JD, Shear MK, Grochocinski VJ, Frank E (1999). Validity and reliability of a new instrument for assessing mood symptomatology: the Structured Clinical Interview for Mood Spectrum (SCI-MOODS). International Journal of Methods in Psychiatric Research 8, 71-82.
16. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry 165, 342-351.
17. Fournier JC, DeRubeis RJ, Shelton RC, Gallop R, Amsterdam JD, Hollon SD (2008). Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder. British Journal of Psychiatry 192, 124-129.
18. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R (2009). Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology 77, 775-787.
19. Frank E, Cassano GB, Rucci P, Fagiolini A, Maggi L, Kraemer HC, Kupfer DJ, Pollock B, Bies R, Nimgaonkar V, Pilkonis P, Shear MK, Thompson WK, Grochocinski VJ, Scocco P, Buttenfield J, Forgione RN (2008). Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression. Clinical Trials 5, 253-261.
20. Frank E, Shear MK, Rucci P, Cyranowski JM, Endicott J, Fagiolini A, Grochocinski VJ, Houck P, Kupfer DJ, Maser JD, Cassano GB (2000). Influence of panic-agoraphobic spectrum symptomatology on treatment response in patients with recurrent major depression. American Journal of Psychiatry 157, 1101-1107.
21. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
22. Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES (1984). Interpersonal Psychotherapy of Depression. Basic Books: New York.
23. Kraemer HC, Wilson GT, Fairburn CG, Agras WS (2002). Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 59, 877-883.
24. Leykin Y, Amsterdam JD, DeRubeis RJ, Gallop R, Shelton RC, Hollon SD (2007). Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. Journal of Consulting and Clinical Psychology 75, 267-276.
25. Mundt JC, Marks IM, Shear MK, Greist JH (2002). The Work and Social Adjustment Scale: a simple measure of impairment in functioning. British Journal of Psychiatry 180, 461-464.
26. Phelps JR, Ghaemi SN (2006). Improving the diagnosis of bipolar disorder: predictive value of screening tests. Journal of Affective Disorders 92, 141-148.
27. Pini S, Abelli M, Mauri M, Muti M, Lazzetta P, Banti S, Cassano GB (2005). Clinical correlates and significance of separation anxiety in patients with bipolar disorder. Bipolar Disorders 7, 370-376.
28. Rucci P, Miniati M, Oppo A, Mula M, Calugi S, Frank E, Shear MK, Mauri M, Pini S, Cassano GB (2009). The structure of lifetime panic-agoraphobic spectrum. Journal of Psychiatric Research 43, 366-379.
29. Rush AJ, O'Neal BL (1999). Patient Rated Inventory of Side Effects (PRISE): unpublished rating scale. University of Texas Southwestern Medical Center: Dallas.
30. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry 163, 1905-1917.
31. Shear MK, Frank E, Rucci P, Fagiolini A, Grochocinski VJ, Houck P, Cassano GB, Kupfer DJ, Endicott J, Maser JD, Mauri M, Banti S (2001). Panic-agoraphobic spectrum: reliability and validity of assessment instruments. Journal of Psychiatric Research 35, 59-66.
32. Sotsky SM, Glass DR, Shea T, Pilkonis PA, Collins JF, Elkin I, Watkins JT, Imber SD, Leber WR, Moyer J, Oliveri ME (1991). Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. American Journal of Psychiatry 148, 997-1008.
33. Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Mendlewicz J (2007). Group for the Study of Resistant Depression. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. Journal of Clinical Psychiatry 68, 1062-1070.
34. Wagner E, Frank E, Steiner S (1992). Discriminating maintenance treatments for recurrent depression: development and implementation of a rating scale. Journal of Psychotherapy Practice and Research 1, 280-290.
35. Weissman MM, Markowitz JC, Klerman GL (2000). Comprehensive Guide to Interpersonal Psychotherapy. Basic Books: New York.